Sign in
Active, not recruitingNo phase

Imaging Quantification of Inflammation (IQI)

Key facts

Who runs it
The Cleveland Clinic
Where
Cleveland, United StatesSee the site
Trial code
Status
Active, not recruiting
People taking part
50 people enrolled
Started
22 Sept 2019
Expected to end
30 Sept 2027
Type of study
Observational
Treatments tested
  • Standard of Care Imaging
Record updated
4 March 2026

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Any patient with a diagnosis of uveitis, who is deemed active or recently active (6 months) by a uveitis specialist

Who cannot take part

  • Those with posterior uveitis, any allergy to fluorescein
  • Poor view in fundus in both eyes which precludes image acquisition in those with posterior uveitis
  • Corneal opacities which prevent image acquisition
  • Inability to sign consent

Where in United States

  • Cleveland Clinic Foundation-Cole Eye InstituteCleveland, United States

About the trial

What the trial wants to find out

1. Perform observational study utilizing real-time quantification of ocular inflammation to determine minimal important change.

Read full original descriptionShow less

Prospective use of changes in imaging quantification of inflammation (IQI) scores in determining treatment decisions both utilizing novel FA viewer software.

The group in the trial

  • Imaging Analysis of patients with uveitis

    Any patient with a diagnosis of uveitis, who is deemed active or recently active (6 months) by a uveitis specialist

    Treatment: Standard of Care Imaging

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
4 March 2026